Vital Strategies Issues Statement on Efficacy of Hydroxychloroquine on COVID-19
May 09, 2020
May 09, 2020
NEW YORK, May 9 -- Vital Strategies issued the following statement by Senior Advisor for Science Neil Schluger:
To date, hydroxychloroquine has been widely administered to COVID-19 patients but with little scientific evidence to support its use.
The New England Journal of Medicine has released results from the largest study of nearly 1,400 patients with moderate to severe COVID-19 and found patients who received the drug did not fare any better than patients who did no . . .
To date, hydroxychloroquine has been widely administered to COVID-19 patients but with little scientific evidence to support its use.
The New England Journal of Medicine has released results from the largest study of nearly 1,400 patients with moderate to severe COVID-19 and found patients who received the drug did not fare any better than patients who did no . . .